Clinical Trial Update: Comparing Endocrine Therapy Combined With High-Dose Palbociclib and Hydroxychloroquine to Endocrine Therapy Combined With Standard-Dose Palbociclib for Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing endocrine therapy with high-dose palbociclib plus hydroxychloroquine versus standard-dose palbociclib with endocrine therapy in hormone …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone Receptor-positive and Advanced Breast Cancer

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• Palbociclib (palbociclib)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer | Phase 3 | Status: NOT_YET_RECRUITING